Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HEG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CADM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLFN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GADD45B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RICTOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
APOBEC3G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHAMM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACBD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KBTBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5C3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMBRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCBLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on